A Randomized, Open-label, Phase II, Multi-center Trial of Gemcitabine (G) With Pazopanib (P) or Gemcitabine (G) With Docetaxel (T) in Previously Treated Subjects With Advanced Soft Tissue Sarcoma
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2017
At a glance
- Drugs Pazopanib (Primary) ; Docetaxel; Gemcitabine
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 21 Jul 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2017.
- 28 Feb 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Mar 2017.
- 22 Jan 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.